At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 18 enrolled
Drug / intervention
BRIMOCHOL™ +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 3-Dose, Multicenter, Randomized, Double-Masked, Crossover Phase 2 Safety and Efficacy Study of BRIMOCHOL™ Topical Ophthalmic Solution vs. BRIMOCHOL™ F Topical Ophthalmic Solution vs. Monotherapy With Carbachol Topical Ophthalmic Solution in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
In Brief
A Phase 2 clinical trial evaluating BRIMOCHOL™, BRIMOCHOL™ F, and 1 other intervention for Presbyopia. Completed, enrolled 18 participants across 3 sites.
Detailed Summary
Safety and Efficacy Study of BRIMOCHOL™ vs. BRIMOCHOL™ F vs. Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartMar 2021
Primary CompletionOct 2021
TodayJul 2026
First PostedMar 1, 2021
Enrollment StartMar 24, 2021
Primary CompletionOct 19, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.3 years ago
Interventions
BRIMOCHOL™drug
A single drop in each eye at a visit.
BRIMOCHOL™ Fdrug
A single drop in each eye at a visit.
Carbacholdrug
A single drop in each eye at a visit.